Feed AFIB
AF

Acutus Medical, Inc.

AFIB · OTC

$0.00 +0.00% (+$0.00)
Market Cap $2.99K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
84 /100
Cheap
EV/EBITDA 9.67x
P/S 0.00x
P/E N/A
Growth
47 /100
Stable
Rev. growth 5.30%
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak
Gross margin 4.98%
FCF margin 157.62%
Net margin 47.36%
Quality
13 /100
Poor
ROIC 0.48%
Asset turnover 0.70x
ROA 33.33%
Debt
22 /100
High
Current ratio 2.06x
Net debt/EBITDA 9.67x
Int. coverage 0.21x
Stability
1 /100
Unstable
Beta 5.79x
Profitable years 0
Rev. volatility 141.12%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o AFIB
Online

O podjetju

Acutus Medical, Inc. is an American company focused on the development and manufacturing of advanced technologies for the treatment of cardiac arrhythmias. The company specializes in innovative technologies and imaging systems that enable physicians to better diagnose and treat cardiac arrhythmias. Their products include electrophysiological cardiac stimulation catheters and imaging systems that allow for precise mapping and navigation during procedures related to cardiac arrhythmias. Acutus Medical is known for its innovative approaches and technological innovations that help physicians provide treatment with high efficacy and safety for patients. Acutus Medical, Inc. shares could be an interesting choice for investors looking for opportunities in the treatment of cardiac diseases and healthcare technologies.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Takeo Mukai

Employees

85

Headquarters

Carlsbad

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

53d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.